Minerva Retained Earnings from 2010 to 2024

NERV Stock

USD 2.26 0.00 0.00%

Minerva Neurosciences Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings are likely to outpace its year average in 2024. Retained Earnings is the cumulative amount of net income that Minerva Neurosciences retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2013-12-31

Previous Quarter

-413.6 M

Current Value

-391.1 M

Quarterly Volatility

59.8 B

Yuan Drop

Covid

Check Minerva Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Minerva Neurosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 29.4 K, Interest Expense of 8.7 M or Selling General Administrative of 10.9 B, as well as many indicators such as Price To Sales Ratio of 1.86, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Minerva financial statements analysis is a perfect complement when working with Minerva Neurosciences Valuation or Volatility modules.

Check out the analysis of Minerva Neurosciences Correlation against competitors.

For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.

Latest Minerva Neurosciences' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Minerva Neurosciences over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Minerva Neurosciences' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Minerva Neurosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (396.82 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Minerva Retained Earnings Regression Statistics

	Arithmetic Mean	(186,446,843)
	Coefficient Of Variation	(77.94)
	Mean Deviation	127,501,044
	Median	(164,381,441)
	Standard Deviation	145,319,169
	Sample Variance	21117.7T
	Range	382.2M
	R-Value	(0.98)
	Mean Square Error	781.3T
	R-Squared	0.97
	Slope	(31,931,304)
	Total Sum of Squares	295647.3T

Minerva Retained Earnings History

	2024	-377 M
	2023	-396.8 M
	2022	-366.8 M
	2021	-334.7 M
	2020	-284.8 M
	2019	-286.7 M
	2018	-214.6 M

Other Fundumenentals of Minerva Neurosciences

Retained Earnings Total Equity

Minerva Neurosciences Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Common Stock	Current Deferred Revenue	Accounts Payable	Good Will	Short Term Debt	Intangible Assets	Property Plant Equipment	Net Tangible Assets	Short Term Investments	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock	Net Receivables
Total Assets		0.76	-0.55	-0.34	0.48	0.96	0.7	0.72	0.63	0.69	0.36	0.39	0.38	0.64	0.72	0.49	0.35	0.63	-0.63	-0.05	-0.05	0.03	-0.06
Total Stockholder Equity	0.76		-0.38	0.26	-0.1	0.66	0.7	0.33	0.19	0.24	0.33	0.83	0.37	0.95	0.68	0.01	0.59	0.24	-0.2	0.55	0.4	0.58	0.46
Net Debt	-0.55	-0.38		0.29	-0.25	-0.55	-0.59	-0.45	-0.6	-0.47	-0.28	-0.11	-0.17	-0.31	-0.08	-0.38	0.17	-0.56	0.5	0.13	0.12	-0.17	0.24
Retained Earnings	-0.34	0.26	0.29		-0.82	-0.42	-0.28	-0.73	-0.7	-0.79	-0.05	0.66	-0.34	0.39	0.0	-0.93	0.52	-0.78	0.83	0.95	0.91	0.64	0.52
Total Liab	0.48	-0.1	-0.25	-0.82		0.58	0.23	0.71	0.74	0.73	0.14	-0.45	-0.01	-0.23	0.24	0.82	-0.22	0.72	-0.75	-0.74	-0.59	-0.59	-0.3
Total Current Assets	0.96	0.66	-0.55	-0.42	0.58		0.67	0.67	0.67	0.65	0.35	0.24	0.29	0.57	0.74	0.6	0.28	0.73	-0.73	-0.15	-0.12	-0.04	-0.07
Common Stock	0.7	0.7	-0.59	-0.28	0.23	0.67		0.63	0.63	0.54	0.29	0.32	0.52	0.6	0.46	0.49	0.09	0.57	-0.59	-0.02	-0.22	0.5	0.33
Current Deferred Revenue	0.72	0.33	-0.45	-0.73	0.71	0.67	0.63		0.74	0.99	0.16	-0.02	0.51	0.14	0.28	0.75	-0.08	0.73	-0.74	-0.5	-0.53	-0.26	-0.17
Accounts Payable	0.63	0.19	-0.6	-0.7	0.74	0.67	0.63	0.74		0.75	0.27	-0.16	0.12	0.08	0.32	0.75	-0.2	0.75	-0.77	-0.55	-0.54	-0.16	-0.26
Good Will	0.69	0.24	-0.47	-0.79	0.73	0.65	0.54	0.99	0.75		0.14	-0.11	0.5	0.06	0.23	0.77	-0.13	0.73	-0.75	-0.58	-0.58	-0.38	-0.33
Short Term Debt	0.36	0.33	-0.28	-0.05	0.14	0.35	0.29	0.16	0.27	0.14		0.32	0.09	0.26	0.26	0.18	-0.16	0.19	-0.23	0.04	-0.01	0.12	0.1
Intangible Assets	0.39	0.83	-0.11	0.66	-0.45	0.24	0.32	-0.02	-0.16	-0.11	0.32		0.11	0.84	0.45	-0.48	0.66	-0.26	0.32	0.85	0.73	0.65	0.52
Property Plant Equipment	0.38	0.37	-0.17	-0.34	-0.01	0.29	0.52	0.51	0.12	0.5	0.09	0.11		0.28	0.27	0.4	0.03	0.31	-0.37	-0.15	-0.4	0.08	-0.08
Net Tangible Assets	0.64	0.95	-0.31	0.39	-0.23	0.57	0.6	0.14	0.08	0.06	0.26	0.84	0.28		0.69	-0.12	0.72	0.1	-0.06	0.66	0.52	0.64	0.46
Short Term Investments	0.72	0.68	-0.08	0.0	0.24	0.74	0.46	0.28	0.32	0.23	0.26	0.45	0.27	0.69		0.22	0.67	0.25	-0.29	0.22	0.19	0.21	0.17
Capital Surpluse	0.49	0.01	-0.38	-0.93	0.82	0.6	0.49	0.75	0.75	0.77	0.18	-0.48	0.4	-0.12	0.22		-0.39	0.91	-0.96	-0.8	-0.83	-0.44	-0.29
Deferred Long Term Liab	0.35	0.59	0.17	0.52	-0.22	0.28	0.09	-0.08	-0.2	-0.13	-0.16	0.66	0.03	0.72	0.67	-0.39		-0.31	0.33	0.67	0.7	0.36	0.3
Short Long Term Debt	0.63	0.24	-0.56	-0.78	0.72	0.73	0.57	0.73	0.75	0.73	0.19	-0.26	0.31	0.1	0.25	0.91	-0.31		-0.98	-0.6	-0.64	-0.31	-0.18
Long Term Debt Total	-0.63	-0.2	0.5	0.83	-0.75	-0.73	-0.59	-0.74	-0.77	-0.75	-0.23	0.32	-0.37	-0.06	-0.29	-0.96	0.33	-0.98		0.66	0.71	0.33	0.21
Net Invested Capital	-0.05	0.55	0.13	0.95	-0.74	-0.15	-0.02	-0.5	-0.55	-0.58	0.04	0.85	-0.15	0.66	0.22	-0.8	0.67	-0.6	0.66		0.92	0.74	0.59
Net Working Capital	-0.05	0.4	0.12	0.91	-0.59	-0.12	-0.22	-0.53	-0.54	-0.58	-0.01	0.73	-0.4	0.52	0.19	-0.83	0.7	-0.64	0.71	0.92		0.53	0.41
Capital Stock	0.03	0.58	-0.17	0.64	-0.59	-0.04	0.5	-0.26	-0.16	-0.38	0.12	0.65	0.08	0.64	0.21	-0.44	0.36	-0.31	0.33	0.74	0.53		0.72
Net Receivables	-0.06	0.46	0.24	0.52	-0.3	-0.07	0.33	-0.17	-0.26	-0.33	0.1	0.52	-0.08	0.46	0.17	-0.29	0.3	-0.18	0.21	0.59	0.41	0.72

Click cells to compare fundamentals

About Minerva Neurosciences Financial Statements

Minerva Neurosciences investors use historical fundamental indicators, such as Minerva Neurosciences' Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Minerva Neurosciences. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Retained Earnings	-396.8 M	-377 M
Retained Earnings Total Equity	-256.3 M	-269.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Minerva Stock Analysis

When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC